From: Pooling analysis regarding the impact of human vitamin D receptor variants on the odds of psoriasis
Models | M | I2 | P heterogeneity | Stratification | case/control (N) | OR [95% CI] | P association | BH |
---|---|---|---|---|---|---|---|---|
allele C vs. A | R | 74.2% | < 0.001 | overall | 1654/1991 (13) | 1.05 [0.85~1.30] | 0.640 | 0.960 |
83.4% | < 0.001 | Asian | 1212/1153 (8) | 0.980 [0.70~1.38] | 0.921 | 0.921 | ||
6.4% | 0.361 | Caucasian | 392/788 (4) | 1.16 [0.96~1.39] | 0.123 | 0.346 | ||
74.6% | < 0.001 | PB | 1312/1650 (12) | 1.02 [0.81~1.30] | 0.849 | 0.856 | ||
57.4% | 0.071 | China | 888/790 (4) | 1.26 [0.99~1.61] | 0.065 | 0.195 | ||
75.8% | < 0.001 | PHWE > 0.05 | 1604/1941 (12) | 1.07 [0.85~1.33] | 0.567 | 0.740 | ||
76.2% | < 0.001 | PCR-RFLP | 770/1041 (9) | 0.93 [0.69~1.27] | 0.668 | 0.819 | ||
CC vs. AA | R | 55.6% | 0.008 | overall | 1654/1991 (13) | 1.11 [0.76~1.64] | 0.585 | 0.960 |
71.9% | 0.001 | Asian | 1212/1153 (8) | 0.91 [0.48~1.71] | 0.761 | 0.921 | ||
0.0% | 0.653 | Caucasian | 392/788 (4) | 1.31 [0.91~1.90] | 0.147 | 0.346 | ||
55.7% | 0.010 | PB | 1312/1650 (12) | 1.04 [0.69~1.59] | 0.838 | 0.856 | ||
72.6% | 0.012 | China | 888/790 (4) | 1.11 [0.76~1.64] | 0.718 | 0.718 | ||
59.3% | 0.005 | PHWE > 0.05 | 1604/1941 (12) | 1.11 [0.74~1.65] | 0.617 | 0.740 | ||
60.5% | 0.009 | PCR-RFLP | 770/1041 (9) | 0.93 [0.52~1.66] | 0.803 | 0.819 | ||
AC vs. AA | R | 61.0% | 0.002 | overall | 1654/1991 (13) | 1.15 [0.85~1.54] | 0.370 | 0.960 |
68.2% | 0.003 | Asian | 1212/1153 (8) | 1.10 [0.70~1.72] | 0.683 | 0.921 | ||
45.9% | 0.136 | Caucasian | 392/788 (4) | 1.27 [0.84~1.91] | 0.257 | 0.346 | ||
64.0% | 0.001 | PB | 1312/1650 (12) | 1.11 [0.78~1.57] | 0.578 | 0.856 | ||
83.2% | < 0.001 | China | 888/790 (4) | 1.15 [0.64~2.07] | 0.638 | 0.718 | ||
60.6% | 0.003 | PHWE > 0.05 | 1604/1941 (12) | 1.20 [0.89~1.63] | 0.235 | 0.478 | ||
62.2% | 0.007 | PCR-RFLP | 770/1041 (9) | 0.94 [0.58~1.54] | 0.819 | 0.819 | ||
AC + CC vs. AA | R | 63.5% | 0.001 | overall | 1654/1991 (13) | 1.15 [0.86~1.54] | 0.356 | 0.960 |
71.6% | 0.001 | Asian | 1212/1153 (8) | 1.06 [0.68~1.66] | 0.800 | 0.921 | ||
43.5% | 0.151 | Caucasian | 392/788 (4) | 1.30 [0.89~1.90] | 0.179 | 0.346 | ||
66.0% | 0.001 | PB | 1312/1650 (12) | 1.10 [0.78~1.55] | 0.595 | 0.856 | ||
79.1% | 0.002 | China | 888/790 (4) | 1.24 [0.75~2.04] | 0.402 | 0.603 | ||
63.6% | 0.001 | PHWE > 0.05 | 1604/1941 (12) | 1.20 [0.89~1.62] | 0.239 | 0.478 | ||
65.8% | 0.003 | PCR-RFLP | 770/1041 (9) | 0.93 [0.57~1.52] | 0.771 | 0.819 | ||
CC vs. AA+AC | R | 63.9% | 0.001 | overall | 1654/1991 (13) | 1.01 [0.74~1.39] | 0.928 | 0.977 |
77.4% | < 0.001 | Asian | 1212/1153 (8) | 0.91 [0.57~1.47] | 0.712 | 0.921 | ||
0.0% | 0.943 | Caucasian | 392/788 (4) | 1.19 [0.86~1.64] | 0.295 | 0.346 | ||
63.8% | 0.001 | PB | 1312/1650 (12) | 0.97 [0.69~1.35] | 0.856 | 0.856 | ||
20.8% | 0.286 | China | 888/790 (4) | 1.26 [0.88~2.14] | 0.205 | 0.410 | ||
66.7% | 0.001 | PHWE > 0.05 | 1604/1941 (12) | 1.00 [0.72~1.39] | 0.977 | 0.977 | ||
69.8% | 0.001 | PCR-RFLP | 770/1041 (9) | 0.93 [0.60~1.42] | 0.727 | 0.819 | ||
carrier C vs. A | F | 42.3% | 0.053 | overall | 1654/1991 (13) | 1.08 [0.96~1.21] | 0.977 | 0.977 |
63.1% | 0.008 | Asian | 1212/1153 (8) | 1.08 [0.93~1.25] | 0.313 | 0.921 | ||
0.0% | 0.720 | Caucasian | 392/788 (4) | 1.10 [0.90~1.34] | 0.346 | 0.346 | ||
43.6% | 0.053 | PB | 1312/1650 (12) | 1.04 [0.92~1.19] | 0.507 | 0.856 | ||
0.0% | 0.578 | China | 888/790 (4) | 1.23 [1.03~1.47] | 0.020 | 0.120 | ||
45.9% | 0.041 | PHWE > 0.05 | 1604/1941 (12) | 1.09 [0.96~1.22] | 0.170 | 0.478 | ||
46.3% | 0.061 | PCR-RFLP | 770/1041 (9) | 0.96 [0.82~1.13] | 0.650 | 0.819 |